Emerging artificial intelligence (AI) software, which can be used with multiple imaging modalities, can improve assessment and coordination of timely care for vascular conditions, including aortic dissection and pulmonary embolism.
The recently released Viz Vascular Suite can be used with a variety of imaging modalities, including computed tomography (CT) and echocardiography, to provide automated analysis of suspicious vascular conditions, according to software maker Viz.ai.
After a vascular condition has been identified, Viz.ai said the Viz Vascular Suite software application sends patient image scans and alerts via HIPAA-compliant means to providers’ mobile devices. Philip Batista, MD, emphasized the ability of the Viz Vascular Suite to promote timely notification and interdisciplinary care for patients with serious vascular conditions.
“When Viz identifies an abnormal scan, it quickly notifies the appropriate specialists, regardless of their location, facilitating seamless communication through the mobile app,” said Dr. Batista, assistant professor of surgery and associate program director for Vascular and Endovascular Surgery Residency at Cooper Rowan University School of Medicine in Camden, NJ “We have been using the Viz software for the past several months and have seen improvements in patient care throughout our institution.”
(Editor’s Note: For related articles, see “AI-Powered Algorithm May Improve CT Evaluation of Aortic Dissection,” “Pie Medical Imaging Launches AI-Powered Echo Platform,” and “FDA Clears Echo Platform Powered by AI to detect heart failure with preserved ejection”. Fraction.”)